e.g. Tata motors, Reliance MF, 500570

Emcure Pharmaceuticals Ltd. - Research Center

544210 EMCURE Group (A) BSE data
 
Back to Company Page
Results:

Half yearly results in brief

(Rs crore)
Sep ' 25 Sep ' 24
Sales 2,357.18 2,074.92
Operating profit 452.59 267.35
Interest 48.25 68.96
Gross profit 448.62 285.82
EPS (Rs) 12.68 6.74

Half yearly  results in details

Sep ' 25 Sep ' 24
Other income 44.28 87.44
Stock adjustment -174.08 -61.72
Raw material 728.80 592.06
Power and fuel - -
Employee expenses 413.10 386.20
Excise - -
Admin and selling expenses - -
Research and development expenses - -
Expenses capitalised - -
Other expenses 936.77 891.03
Provisions made - -
Depreciation 121.56 111.41
Taxation 83.15 47.04
Net profit / loss 240.41 127.37
Extra ordinary item -3.50 -
Prior year adjustments - -
Equity capital 189.57 189.10
Equity dividend rate - -
Agg.of non-prom. shares (Lacs) - -
Agg.of non promotoholding (%) - -
OPM (%) 19.20 12.88
GPM (%) 18.68 13.22
NPM (%) 10.01 5.89
Close
Add Emcure Pharmaceuticals Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Emcure Pharmaceuticals Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close

Home

Market News

Latest News

International Markets

Economy

Industries

Mutual Fund News

IPO News

Search News

My Portfolio

My Watchlist

Gainers

Losers

Sectors

Indices

Forex

Mutual Funds

Feedback